NO20000230L - Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor - Google Patents

Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor

Info

Publication number
NO20000230L
NO20000230L NO20000230A NO20000230A NO20000230L NO 20000230 L NO20000230 L NO 20000230L NO 20000230 A NO20000230 A NO 20000230A NO 20000230 A NO20000230 A NO 20000230A NO 20000230 L NO20000230 L NO 20000230L
Authority
NO
Norway
Prior art keywords
glucosidase inhibitor
thiazolidinedione
alfa
diabetes
treatment
Prior art date
Application number
NO20000230A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000230D0 (no
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000230D0 publication Critical patent/NO20000230D0/no
Publication of NO20000230L publication Critical patent/NO20000230L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO20000230A 1997-07-18 2000-01-17 Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor NO20000230L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (2)

Publication Number Publication Date
NO20000230D0 NO20000230D0 (no) 2000-01-17
NO20000230L true NO20000230L (no) 2000-01-17

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000230A NO20000230L (no) 1997-07-18 2000-01-17 Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor

Country Status (27)

Country Link
EP (1) EP1001784A1 (sk)
JP (1) JP2001510160A (sk)
KR (1) KR20010021952A (sk)
CN (1) CN1263467A (sk)
AP (1) AP2000001735A0 (sk)
AR (2) AR016350A1 (sk)
AU (1) AU8449098A (sk)
BG (1) BG104062A (sk)
BR (1) BR9810292A (sk)
CA (1) CA2297133A1 (sk)
CO (1) CO4940489A1 (sk)
DZ (1) DZ2563A1 (sk)
EA (1) EA200000140A1 (sk)
GB (1) GB9715298D0 (sk)
HU (1) HUP0003626A3 (sk)
ID (1) ID23804A (sk)
IL (1) IL133907A0 (sk)
MA (1) MA24608A1 (sk)
NO (1) NO20000230L (sk)
OA (1) OA11312A (sk)
PE (1) PE99499A1 (sk)
PL (1) PL338140A1 (sk)
SK (1) SK612000A3 (sk)
TR (1) TR200000133T2 (sk)
UY (1) UY25101A1 (sk)
WO (1) WO1999003478A1 (sk)
ZA (1) ZA986364B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP1849475A1 (en) 1999-06-21 2007-10-31 Eli Lilly &amp; Company Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
ATE346613T1 (de) * 2000-01-21 2006-12-15 Novartis Pharma Gmbh Zusammensetzungen bestehend aus dipeptidylpeptidase-iv inhibitoren und antidiabetica
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
CA2401356A1 (en) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Combination drug
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
WO2005041962A1 (en) 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR016350A1 (es) 2001-07-04
BG104062A (en) 2000-11-30
SK612000A3 (en) 2000-07-11
MA24608A1 (fr) 1999-04-01
CA2297133A1 (en) 1999-01-28
PL338140A1 (en) 2000-09-25
JP2001510160A (ja) 2001-07-31
BR9810292A (pt) 2000-09-19
UY25101A1 (es) 2000-12-29
PE99499A1 (es) 1999-12-18
CO4940489A1 (es) 2000-07-24
WO1999003478A1 (en) 1999-01-28
KR20010021952A (ko) 2001-03-15
NO20000230D0 (no) 2000-01-17
GB9715298D0 (en) 1997-09-24
DZ2563A1 (fr) 2003-02-15
ID23804A (id) 2000-05-11
HUP0003626A2 (hu) 2001-05-28
HUP0003626A3 (en) 2001-12-28
CN1263467A (zh) 2000-08-16
ZA986364B (en) 2000-01-17
EP1001784A1 (en) 2000-05-24
IL133907A0 (en) 2001-04-30
EA200000140A1 (ru) 2000-06-26
AR019724A2 (es) 2002-03-13
TR200000133T2 (tr) 2000-09-21
AP2000001735A0 (en) 2000-01-16
AU8449098A (en) 1999-02-10
OA11312A (en) 2003-10-24

Similar Documents

Publication Publication Date Title
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20000230L (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og &lt;alfa&gt;glukosidaseinhibitor
SE9803760D0 (sv) Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
WO2001091774A3 (en) Method of treating chronic ulcers
CA2296653A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
NO996270L (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
HUP0003260A2 (hu) Gyógyszerkészítmény diabetes kezelésére rosziglitazonnal és inzulinnal
HUP0104388A2 (hu) Béta-agonistákból és további antidiabetikus szerekből álló kombinációk
UY25103A1 (es) Composición para el tratamiento de diabetes mellitus
ES2135353A1 (es) Utilizacion del 17beta-estradiol, sus analogos y derivados en el tratamiento de la diabetes mellitus y sus manifestaciones.
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
CO5150158A1 (es) Tratamiento antidiabetico novedoso
ECSP982542A (es) Nuevo metodo de tratamiento iii
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
HUP0002569A2 (hu) Diabetes kezelésére alkalmas dioxo-tiazolidint és alfa-glükozidáz inhibitort tartalmazó gyógyszerkészítmények
ECSP982593A (es) Nuevo metodo de tratamiento vi
ECSP982534A (es) Nuevo metodo de tratamiento
ECSP982591A (es) Nuevo metodo de tratamiento iv
ECSP982535A (es) Nuevo metodo de tratamiento (i)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application